REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Solmedical Sas (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Pharmaceutical Preparation Manufacturing | Pharmacies and Drug Stores | Corporate, Subsidiary, and Regional Managing Offices
Full name: Solmedical Sas Profile Updated: June 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Administrar,fabricar Distribuir Importar Exportar Representar Outsourcing Joint Venture de Productos , Materias Primas Productos de Cualquier Naturaleza Terminados, Equipos Suministros Accesorios

Headquarters
Cl 24 Norte # 8 N - 50
Cali; Valle del Cauca;

Contact Details: Purchase the Solmedical Sas report to view the information.

Basic Information
Total Employees:
Purchase the Solmedical Sas report to view the information.
Registered Capital:
Purchase the Solmedical Sas report to view the information.
Financial Auditors:
Purchase the Solmedical Sas report to view the information.
Incorporation Date:
May 29, 2001
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Deputy Manager
Purchase this report to view the information.
Deputy Manager
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Subsidiaries
Biotefar S.A.S.
15%
Company Performance
Financial values in the chart are available after Solmedical Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-47.41%▼
Total operating revenue
-45.35%▼
Operating profit (EBIT)
-59.96%▼
EBITDA
-71.29%▼
Net Profit (Loss) for the Period
N/A
Total assets
-19.89%▼
Total equity
N/A
Operating Profit Margin (ROS)
-9.89%▼
Net Profit Margin
N/A
Return on Equity (ROE)
-30.83%▼
Debt to Equity Ratio
N/A
Quick Ratio
-2.44%▼
Cash Ratio
-0.15%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo